Treatment of patients with cancer of an unknown primary site

Keyphrases

• Patients with Cancer 100%
• Clinical Group 100%
• Unknown Primary Site 100%
• Malignancy 66%
• Tumor 66%
• Clinical Trials 33%
• Pathological Diagnosis 33%
• Treatment Modalities 33%
• Histology 33%
• Systemic Therapy 33%
• Treatment Effect 33%
• Molecular Targets 33%
• Head-and-neck Cancer 33%
• Cytotoxic Drugs 33%
• Targeted Therapy 33%
• Breast Cancer 33%
• Poor Prognosis 33%
• Taxanes 33%
• Specific Marker 33%
• Platinum Agents 33%
• Clinical Staging 33%
• Clinical Prognosis 33%
• Specific Treatment 33%
• Heterogenous Groups 33%
• Cancer of Unknown Primary 33%

Medicine and Dentistry

• Cancer of Unknown Primary Origin 100%
• Cancer of Unknown Primary 100%
• Cancer 66%
• Clinical Trial 33%
• Neoplasm 33%
• Targeted Therapy 33%
• Breast Cancer 33%
• Head and Neck Cancer 33%
• Treatment Effect 33%
• Systemic Therapy 33%
• Tumor 33%
• Diseases 33%
• Molecular Marker 33%
• Cytotoxic Agent 33%
• Treatment Modality 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Cancer of Unknown Primary Site 100%
• Neoplasm 50%
• Clinical Trial 50%
• Breast Cancer 50%
• Head and Neck Cancer 50%
• Taxane 50%
• Diseases 50%
• Cytotoxic Agent 50%
• Molecular Marker 50%